Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joshua Rosenow

Neurological Surgery Chicago, IL Medical Doctor

NPI 1053336776 CMS profile 274831

680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611

Open in the dashboard

General payments

$152,087

126 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$299,905 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Joshua Rosenow of Chicago, IL is reported in the CMS Open Payments database as having received $152,087 across 126 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $299,905 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,618 16
2024 General $28,376 20
2023 General $56,915 26
2022 General $14,350 18
2021 General $15,629 15
2020 General $9,089 11
2019 General $24,110 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Rosenow
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Joshua Rosenow were reported at $3,618. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Joshua Rosenow Neurological Surgery median Middle half National median
2019 $24,110 $582 $138–$3,006 $163
2020 $9,089 $294 $76–$2,174 $114
2021 $15,629 $387 $105–$2,432 $132
2022 $14,350 $542 $139–$2,989 $149
2023 $56,915 $534 $145–$2,697 $160
2024 $28,376 $574 $155–$3,046 $164
2025 $3,618 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $127,351 79 payments
  2. Stryker Corporation $13,820 13 payments
  3. Monteris Medical Corporation $6,575 9 payments
  4. InSightec,Inc $1,854 10 payments
  5. Saluda Medical Americas, Inc. $1,562 3 payments
  6. Medtronic, Inc. $486 2 payments
  7. Abbott Laboratories $245 7 payments
  8. Sunovion Pharmaceuticals Inc. $123 1 payment
  9. Vertex Pharmaceuticals Incorporated $53 1 payment
  10. Stimwave Technologies Incorporated $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $104,606 41 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $39,682 27 payments
  3. Travel and Lodging $3,809 10 payments
  4. Food and Beverage $3,634 47 payments
  5. Grant $356 1 payment
Products named General payments · program years 2019–2025
  1. Precision $32,025 7 payments
  2. SPECTRA WAVEWRITER Pain Management $25,142 17 payments
  3. AIRO $10,738 10 payments
  4. Neuroblate $6,575 9 payments
  5. GENERAL PAIN MANAGEMENT $6,543 6 payments
  6. GENERAL DBS $5,775 4 payments
  7. SPECTRA WAVEWRITER Pain Management $3,575 2 payments
  8. GENERAL - PAIN MANAGEMENT $3,300 3 payments
  9. SPINEMAP $3,000 2 payments
  10. WAVEWRITER ALPHA $2,604 5 payments
  11. Other $12,776 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

112

Median for Neurosurgery: 83

Drug cost

$535

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 82 $449
Cephalexin Generic 30 $86

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$158,171

Medicare's payments for the services billed

Medicare patients

210

Average age 69

Services billed

427

91 women, 119 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 60%
Depression 34%
Ischemic heart disease 30%
Diabetes 24%
Osteoporosis 23%
Chronic kidney disease 18%
Cancer 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

126 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record